◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksM › MDLN

Medline Inc. Class A Common Stock (MDLN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-09-19

Medline Inc. Class A Common Stock (MDLN) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Northfield, United States with about 45,000 employees. Its market capitalization is roughly $43 billion. In the fiscal year ended 2025-12-31, MDLN reported $28.4B in revenue and $1.2B in net income.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions.

Interactive charts & full statements → Open the MDLN valuation workbench →

MDLN Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-31
Total Revenue$29.9B$28.4B$25.5B$23.2B$21.4B
Gross Profit$7.5B$7.5B$6.3B$5.2B$4.6B
Gross Margin %25.0%26.4%24.7%22.5%21.2%
Operating Income (EBIT)$1.8B$2.2B$2.2B$1.4B$870M
Operating Margin %6.1%7.8%8.7%6.2%4.1%
Net Income$691M$1.2B$1.2B$234M($25M)
Net Margin %2.3%4.1%4.7%1.0%-0.1%
EBITDA$2.0B$3.5B$2.6B$1.9B
Earnings Per Share (EPS)$0.86$1.43$1.52$0.30$-0.03
Shares Outstanding (M)812M787M787M787M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-09-302024-06-30
Total Revenue$7.7B$7.4B$7.8B$7.1B$6.9B$6.6B$6.4B$6.2B
Gross Profit$2.2B$1.7B$1.9B$1.7B$1.7B$1.6B$1.6B$1.5B
Gross Margin %28.8%22.7%24.6%23.9%25.1%24.8%24.8%24.2%
Operating Income (EBIT)$395M$422M$425M$574M$629M$591M$574M$516M
Operating Margin %5.1%5.7%5.5%8.1%9.1%8.9%9.0%8.3%
Net Income$60M$129M$180M$322M$333M$322M$324M$292M
Net Margin %0.8%1.8%2.3%4.5%4.8%4.9%5.1%4.7%
EBITDA$681M$382M$826M$842M$799M$760M$806M
Earnings Per Share (EPS)$0.07$0.16$0.22$0.41$0.42$0.40$0.41$0.37
Shares Outstanding (M)825M812M787M787M800M787M787M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-31
Cash from Operations (CFO)$2.0B$1.7B$1.8B$1.7B$187M
Capital Expenditures (CapEx)$650M$447M$364M$285M$254M
Free Cash Flow (FCF)$1.3B$1.3B$1.4B$1.4B($67M)
FCF Margin %4.5%4.6%5.5%6.0%-0.3%
Dividends Paid$518M$114M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-09-30
Cash from Operations (CFO)$715M$412M$229M$636M$243M$636M$722M
Capital Expenditures (CapEx)$111M$96M$342M$101M$140M$101M$107M
Free Cash Flow (FCF)$604M$316M($113M)$535M$103M$535M$615M
FCF Margin %7.9%4.3%-1.5%7.5%1.5%8.1%9.6%
Dividends Paid$96M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MDLN Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-31
Total Assets$39.4B$38.5B$36.0B$36.1B
Cash & Cash Equivalents$2.3B$1.9B$250M$1.6B
Total Liabilities$20.3B$19.2B$19.5B$19.1B
Total Debt (Short + Long-Term)$12.6B$12.6B$154M$122M
Total Shareholders' Equity$11.6B$10.7B$16.5B$17.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDLN viewer.

MDLN Metric Deep Dives

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← MDIVAll “M” companiesMDLV →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.